Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Management of Osteoporosis in Elderly Patients with Fragility Fractures

Assessment and Diagnosis

  • A hip fracture in a 78-year-old patient is considered a fragility fracture, which strongly indicates underlying osteoporosis and significantly increases the risk of subsequent fractures 1, 2
  • The risk of subsequent fracture is highest immediately after the initial fracture and gradually decreases over time, making prompt intervention critical 1

Treatment Recommendations

  • All patients should receive calcium (1200 mg/day) and vitamin D3 (800-1000 IU/day) supplementation along with bisphosphonate therapy 3, 2
  • Vitamin D levels should be checked at the same time as the DEXA scan to guide supplementation dosing 3

Monitoring and Follow-up

  • A baseline DEXA scan should be obtained to assess initial BMD and to monitor treatment response 3
  • Follow-up DEXA scan is recommended after 1-2 years of therapy to assess treatment effectiveness 3
  • Monitoring for adverse effects of bisphosphonates is essential, particularly for gastrointestinal side effects with oral formulations 4
  • Rare but serious complications like atypical femoral fractures with long-term use (typically after 3-5 years) can occur 5

Important Considerations and Caveats

  • Hip fractures carry a 20% mortality rate within the first year, making aggressive treatment essential 6
  • For patients with advanced degenerative changes in the spine that may affect DEXA interpretation, quantitative CT may be considered as an alternative 6
  • Fracture Liaison Services have been shown to significantly improve osteoporosis treatment after fragility fractures (45% vs 26% in control groups) 1